Epigral

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,041.90",
    "chg": 51.5,
    "chgp": "5.2%",
    "dir": 1,
    "prev_price": "990.40",
    "mcapval": "4,370.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE071N01016",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "1.11 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd Falls 4.65% Amid Volatility: 2 Key Trading Days Define Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-falls-465-amid-volatility-2-key-trading-days-define-week-3825927",
        "imagepath": "",
        "date": "2026-02-07 11:02:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock hits 52-week low at Rs.933.45 amid ongoing downtrend</p>\n                    <p><strong>3 Feb:</strong> Strong intraday rally with 7.8% surge to Rs.1,001.65</p>\n                    <p><strong>4 Feb:</strong> Minor correction with a 0.71% decline</p>\n                    <p><strong>5 Feb:</strong> Continued downward pressure, closing at Rs.1,003.85</p>\n                    <p><strong>6 Feb:</strong> Week ends with a 1.34% drop to Rs.990.40</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs..."
      },
      {
        "title": "Epigral Ltd Hits Intraday High with Strong 7.8% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-strong-78-surge-on-3-feb-2026-3818542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_priceRelatedfactors_3818542.png",
        "date": "2026-02-03 12:01:26",
        "description": "Epigral Ltd recorded a robust intraday performance on 3 Feb 2026, surging to a day’s high of Rs 1001.65, marking a 7.98% increase from the previous close. The stock outperformed its sector and the broader market, reflecting notable trading momentum within the Specialty Chemicals industry."
      },
      {
        "title": "Epigral Ltd Stock Falls to 52-Week Low of Rs.933.45 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-stock-falls-to-52-week-low-of-rs93345-amid-continued-downtrend-3816145",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_priceRelatedfactors_3816145.png",
        "date": "2026-02-02 10:00:11",
        "description": "Epigral Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.933.45 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics."
      },
      {
        "title": "Epigral Ltd Hits Intraday Low Amidst Significant Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-hits-intraday-low-amidst-significant-price-pressure-3814844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_priceRelatedfactors_3814844.png",
        "date": "2026-02-01 15:32:17",
        "description": "Epigral Ltd’s shares declined sharply today, touching an intraday low of Rs 965, marking a new 52-week low as the stock underperformed both its sector and the broader market amid widespread selling pressure."
      },
      {
        "title": "Epigral Ltd Stock Falls to 52-Week Low Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-stock-falls-to-52-week-low-amidst-continued-underperformance-3814575",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_priceRelatedfactors_3814575.png",
        "date": "2026-02-01 12:12:15",
        "description": "Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low, closing just 0.02% above its lowest price of Rs 997.7. This marks a significant point in the stock’s recent trajectory, reflecting ongoing challenges in both its near-term and long-term performance metrics."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-3813966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/EpigralLtd_mojoScore_3813966.png",
        "date": "2026-02-01 10:10:56",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Are Epigral Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-epigral-ltd-latest-results-good-or-bad-3813390",
        "imagepath": "",
        "date": "2026-01-31 19:29:53",
        "description": "Epigral Ltd's latest financial results for Q3 FY26 reveal a company facing significant operational challenges. The net sales for the quarter were reported at ₹597.12 crores, reflecting a year-on-year decline of 7.46%, although there was a modest sequential growth of 1.66% compared to the previous quarter. This suggests some stability in revenue on a short-term basis, but the overall trend remains concerning.\n\nThe net profit after tax for the quarter was ₹39.11 crores, which represents a substantial decline of 62.26% year-on-year and a decrease of 23.64% from the previous quarter. This sharp drop in profitability is indicative of deeper issues within the company's operational framework. The profit margins are also under pressure, with the operating margin (excluding other income) falling to 17.21%, marking the lowest level in seven quarters and a significant contraction from 28.29% in the same quarter last y..."
      },
      {
        "title": "Epigral Ltd Falls 2.54% Amidst 52-Week Lows and Earnings Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-falls-254-amidst-52-week-lows-and-earnings-pressure-3812693",
        "imagepath": "",
        "date": "2026-01-31 11:03:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> New 52-week low at Rs.1,045.55</p>\n                    <p><strong>Jan 28:</strong> Further 52-week low at Rs.1,044.10</p>\n                    <p><strong>Jan 29:</strong> Stock hits Rs.1,034.15, continuing downtrend</p>\n                    <p><strong>Jan 30:</strong> Fresh 52-week low of Rs.1,010.85 despite intraday recovery</p>\n                    <p><strong>Jan 30:</strong> Q3 FY26 results reveal margin compression and profit decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,065.75</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "Epigral Q3 FY26: Margin Compression and Profit Decline Signal Growing Headwinds",
        "link": "https://www.marketsmojo.com/news/result-analysis/epigral-q3-fy26-margin-compression-and-profit-decline-signal-growing-headwinds-3811978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/Epigral_quaterlyResult_3811978.png",
        "date": "2026-01-30 17:48:51",
        "description": "Epigral Ltd., a small-cap specialty chemicals manufacturer with a market capitalisation of ₹4,463 crores, reported a consolidated net profit of ₹39.11 crores for Q3 FY26, marking a sharp decline of 62.26% year-on-year and 23.64% quarter-on-quarter. The results underscore mounting operational challenges as the company grapples with severe margin compression and weakening profitability despite marginal revenue growth."
      }
    ],
    "total": 587,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "06-Feb-2026",
      "details": "Epigral Limited has informed the Exchange about Participation in Conference and One-on-One Meeting with Analyst / Investor on 10.02.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Feb-2026",
      "details": "Epigral Limited submits Transcript of Conference Call held on Friday 30th January 2026 for Q3 FY26 - Results.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "03-Feb-2026",
      "details": "Epigral Limited submits Press release titled Epigral Limited awarded EcoVadis Silver Medal.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>25%</strong> dividend, ex-date: 07 Feb 25",
          "dt": "2025-02-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Epigral Ltd Falls 4.65% Amid Volatility: 2 Key Trading Days Define Week

2026-02-07 11:02:06

Key Events This Week

2 Feb: Stock hits 52-week low at Rs.933.45 amid ongoing downtrend

3 Feb: Strong intraday rally with 7.8% surge to Rs.1,001.65

4 Feb: Minor correction with a 0.71% decline

5 Feb: Continued downward pressure, closing at Rs.1,003.85

6 Feb: Week ends with a 1.34% drop to Rs.990.40

Week Open

Rs...

Read full news article

Epigral Ltd Hits Intraday High with Strong 7.8% Surge on 3 Feb 2026

2026-02-03 12:01:26

Epigral Ltd recorded a robust intraday performance on 3 Feb 2026, surging to a day’s high of Rs 1001.65, marking a 7.98% increase from the previous close. The stock outperformed its sector and the broader market, reflecting notable trading momentum within the Specialty Chemicals industry.

Read full news article

Epigral Ltd Stock Falls to 52-Week Low of Rs.933.45 Amid Continued Downtrend

2026-02-02 10:00:11

Epigral Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.933.45 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Read full news article

Epigral Ltd Hits Intraday Low Amidst Significant Price Pressure

2026-02-01 15:32:17

Epigral Ltd’s shares declined sharply today, touching an intraday low of Rs 965, marking a new 52-week low as the stock underperformed both its sector and the broader market amid widespread selling pressure.

Read full news article

Epigral Ltd Stock Falls to 52-Week Low Amidst Continued Underperformance

2026-02-01 12:12:15

Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low, closing just 0.02% above its lowest price of Rs 997.7. This marks a significant point in the stock’s recent trajectory, reflecting ongoing challenges in both its near-term and long-term performance metrics.

Read full news article

Epigral Ltd is Rated Sell

2026-02-01 10:10:56

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Epigral Ltd latest results good or bad?

2026-01-31 19:29:53

Epigral Ltd's latest financial results for Q3 FY26 reveal a company facing significant operational challenges. The net sales for the quarter were reported at ₹597.12 crores, reflecting a year-on-year decline of 7.46%, although there was a modest sequential growth of 1.66% compared to the previous quarter. This suggests some stability in revenue on a short-term basis, but the overall trend remains concerning. The net profit after tax for the quarter was ₹39.11 crores, which represents a substantial decline of 62.26% year-on-year and a decrease of 23.64% from the previous quarter. This sharp drop in profitability is indicative of deeper issues within the company's operational framework. The profit margins are also under pressure, with the operating margin (excluding other income) falling to 17.21%, marking the lowest level in seven quarters and a significant contraction from 28.29% in the same quarter last y...

Read full news article

Epigral Ltd Falls 2.54% Amidst 52-Week Lows and Earnings Pressure

2026-01-31 11:03:51

Key Events This Week

Jan 27: New 52-week low at Rs.1,045.55

Jan 28: Further 52-week low at Rs.1,044.10

Jan 29: Stock hits Rs.1,034.15, continuing downtrend

Jan 30: Fresh 52-week low of Rs.1,010.85 despite intraday recovery

Jan 30: Q3 FY26 results reveal margin compression and profit decline

Week Open

Rs.1,065.75

Read full news article

Epigral Q3 FY26: Margin Compression and Profit Decline Signal Growing Headwinds

2026-01-30 17:48:51

Epigral Ltd., a small-cap specialty chemicals manufacturer with a market capitalisation of ₹4,463 crores, reported a consolidated net profit of ₹39.11 crores for Q3 FY26, marking a sharp decline of 62.26% year-on-year and 23.64% quarter-on-quarter. The results underscore mounting operational challenges as the company grapples with severe margin compression and weakening profitability despite marginal revenue growth.

Read full news article

View All News